Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples